UK Life Sciences Company Directory

Clinical-stage CNS drug discovery using human brain genomics

Cerevance is a clinical-stage biotechnology company developing small molecule therapeutics for neurodegenerative and psychiatric disorders. The company uses its proprietary…

Industry collaboration network for biopharmaceutical manufacturing and operations

BioPhorum is a UK-based membership organisation that brings together senior leaders and subject matter experts from global biopharmaceutical manufacturers, CDMOs, and suppliers to…

Contract proteomics CRO and inventor of TMT isobaric mass tags

Proteome Sciences is a contract proteomics organisation and reagent manufacturer specialising in mass spectrometry-based protein biomarker discovery, validation, and targeted…

Digital cognitive assessment and CNS clinical trial software platform

Cambridge Cognition provides digital cognitive assessment and clinical trial technology for central nervous system drug development. Its validated computerised tests measure…

In vivo lentiviral CAR/TCR cell therapy platform for ovarian cancer

Akimbo Bio is an early-stage biotechnology company developing next-generation in vivo lentiviral vector technology for cell therapy. Its lead platform carries a dual CAR/TCR…

Antibody discovery biotech targeting GPCRs in inflammatory disease

DJS Antibodies is a biotechnology company developing monoclonal antibody therapeutics against G protein-coupled receptors and other previously intractable disease targets. Its…

Clinical-stage oncology company advancing in-licensed cancer drug assets

Ellipses Pharma is a clinical-stage oncology drug development company that in-licenses cancer drug assets from academia and industry, advances them through clinical trials using a…

Rejuvenation biology company decoding the genomics of cellular ageing reversal

clock.health is a biotechnology company developing therapies to reverse cellular ageing and extend healthspan by decoding the biological programmes that govern cell rejuvenation.…

Cambridge R&D hub for GPCR-based drug discovery

Nxera Pharma UK is the Cambridge-based drug discovery arm of Tokyo-listed Nxera Pharma, formerly Sosei Heptares, operating from Granta Park with approximately 170 scientists. Its…

Oncolytic virus platform for tumour-targeted cancer immunotherapy

Accession Therapeutics is a clinical-stage biotechnology company developing tumour-targeted immunotherapies based on its proprietary oncolytic virus platform. Designed for…

siRNA gene therapies targeting root causes of ALS and frontotemporal dementia

Crucible Therapeutics Limited is a preclinical-stage biotechnology company developing siRNA-based gene therapies for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia…

CRO-CDMO process chemistry and API manufacturing centre for global pharma partners

Sai Life Sciences operates a UK research and development site providing contract research and development and manufacturing services to global biotech and pharmaceutical…